This recent ASCO guideline documents the evidence in support of the use of cannabis and cannabinoids in adults with cancer. The guideline highlights the lack of evidence for the use of cannabis and cannabinoids as a cancer-directed therapy and recommends discouraging their use in this regard. The limited evidence available supporting the role of cannabis and cannabinoids as an adjuvant supportive therapy is reviewed.
The guideline will help inform clear and nonjudgmental communication between providers and patients with cancer in regard to the use of cannabis and cannabinoid products.
(Source: ASCO Guidelines on Cannabis and Cannabinoid Use in Adults With Cancer | PracticeUpdate)
Also see
- Cannabis Causing Cancer
- Cannabis & Children’s Cancer:
- Epidemiological overview of multidimensional chromosomal and genome toxicity of cannabis exposure in congenital anomalies and cancer development
- Cannabis oil failed to improve pain or quality of life in palliative care cancer patients, study shows